Cargando…
Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination
W present a rare case of cerebral venous sinus thrombosis after the BNT162b2 mRNA COVID-19 vaccine. A 61-year-old Japanese man developed a headache 10 days after the first dose of the vaccine. Magnetic resonance venography and contrast-enhanced brain MRI showed thrombosis in the superior sagittal si...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590453/ https://www.ncbi.nlm.nih.gov/pubmed/34796065 http://dx.doi.org/10.7759/cureus.18775 |
_version_ | 1784598969200934912 |
---|---|
author | Yamaguchi, Yoshitaka Kimihira, Luna Nagasawa, Hikaru Seo, Kyoichi Wada, Manabu |
author_facet | Yamaguchi, Yoshitaka Kimihira, Luna Nagasawa, Hikaru Seo, Kyoichi Wada, Manabu |
author_sort | Yamaguchi, Yoshitaka |
collection | PubMed |
description | W present a rare case of cerebral venous sinus thrombosis after the BNT162b2 mRNA COVID-19 vaccine. A 61-year-old Japanese man developed a headache 10 days after the first dose of the vaccine. Magnetic resonance venography and contrast-enhanced brain MRI showed thrombosis in the superior sagittal sinus and the right transverse sinus. Anticoagulation with intravenous unfractionated heparin followed by oral warfarin was started. His headache improved, and brain MRI on day 22 showed resolution of thrombus. He was maintained on anticoagulation with warfarin and discharged without any neurological sequelae. This case is presented in the context of the relevant literature. |
format | Online Article Text |
id | pubmed-8590453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-85904532021-11-17 Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination Yamaguchi, Yoshitaka Kimihira, Luna Nagasawa, Hikaru Seo, Kyoichi Wada, Manabu Cureus Neurology W present a rare case of cerebral venous sinus thrombosis after the BNT162b2 mRNA COVID-19 vaccine. A 61-year-old Japanese man developed a headache 10 days after the first dose of the vaccine. Magnetic resonance venography and contrast-enhanced brain MRI showed thrombosis in the superior sagittal sinus and the right transverse sinus. Anticoagulation with intravenous unfractionated heparin followed by oral warfarin was started. His headache improved, and brain MRI on day 22 showed resolution of thrombus. He was maintained on anticoagulation with warfarin and discharged without any neurological sequelae. This case is presented in the context of the relevant literature. Cureus 2021-10-14 /pmc/articles/PMC8590453/ /pubmed/34796065 http://dx.doi.org/10.7759/cureus.18775 Text en Copyright © 2021, Yamaguchi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurology Yamaguchi, Yoshitaka Kimihira, Luna Nagasawa, Hikaru Seo, Kyoichi Wada, Manabu Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination |
title | Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination |
title_full | Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination |
title_fullStr | Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination |
title_full_unstemmed | Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination |
title_short | Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination |
title_sort | cerebral venous sinus thrombosis after bnt162b2 mrna covid-19 vaccination |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590453/ https://www.ncbi.nlm.nih.gov/pubmed/34796065 http://dx.doi.org/10.7759/cureus.18775 |
work_keys_str_mv | AT yamaguchiyoshitaka cerebralvenoussinusthrombosisafterbnt162b2mrnacovid19vaccination AT kimihiraluna cerebralvenoussinusthrombosisafterbnt162b2mrnacovid19vaccination AT nagasawahikaru cerebralvenoussinusthrombosisafterbnt162b2mrnacovid19vaccination AT seokyoichi cerebralvenoussinusthrombosisafterbnt162b2mrnacovid19vaccination AT wadamanabu cerebralvenoussinusthrombosisafterbnt162b2mrnacovid19vaccination |